NiKang Therapeutics has a total of 104 patents globally, out of which 8 have been granted. Of these 104 patents, more than 79% patents are active. The USA is where NiKang Therapeutics has filed the maximum number of patents, followed by Europe (EPO) and Taiwan. Parallelly, the USA seems to be the main focused R&D center of NiKang Therapeutics and is also the origin country of the firm.
NiKang Therapeutics was founded in the year 2017 by Yan Lou and Zhenhai Gao. The company is a biotech company focused on discovering and developing small molecule oncology medicines.
Do read about some of the most popular patents of NiKang Therapeutics which have been covered by us in this article and also you can find NiKang Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over NiKang Therapeutics patent portfolio.
How many patents does NiKang Therapeutics have?
NiKang Therapeutics has a total of 104 patents globally. These patents belong to 18 unique patent families. Out of 104 patents, 83 patents are active.How Many Patents did NiKang Therapeutics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.Year of Patents Filing or Grant | NiKang Therapeutics Applications Filed | NiKang Therapeutics Patents Granted |
2022 | 17 | 5 |
2021 | 35 | 2 |
2020 | 23 | – |
2019 | 27 | – |
2018 | – | – |
2017 | – | – |
How many NiKang Therapeutics patents are Alive/Dead?
Worldwide PatentsHow Many Patents did NiKang Therapeutics File in Different Countries?
Countries in which NiKang Therapeutics Filed PatentsCountry | Patents |
United States Of America | 19 |
Europe | 9 |
Taiwan | 8 |
Canada | 6 |
Australia | 6 |
Hong Kong (S.A.R.) | 5 |
China | 4 |
Israel | 4 |
Singapore | 3 |
South Africa | 2 |
Mexico | 2 |
Brazil | 2 |
India | 2 |
Colombia | 1 |
Costa Rica | 1 |
Philippines | 1 |
Indonesia | 1 |
Chile | 1 |
Where are Research Centres of NiKang Therapeutics Patents Located?
10 Best NiKang Therapeutics Patents
US20200115389A1 is the most popular patent in the NiKang Therapeutics portfolio. It has received 12 citations so far from companies like Relay Therapeutics and D. E. Shaw Research. Below is the list of 10 most cited patents of NiKang Therapeutics:Publication Number | Citation Count |
US20200115389A1 | 12 |
WO2020081695A1 | 11 |
WO2021016280A1 | 9 |
US11034705B2 | 8 |
WO2021212062A1 | 5 |
CN112118891A | 4 |
WO2022187528A1 | 4 |
WO2020205835A1 | 4 |
WO2020055883A1 | 4 |
US10894797B2 | 3 |